Healio (9/6, Welsh) reports, “Use of postnatal selective serotonin reuptake inhibitors” (SSRIs) “was associated with reduced risks for maternal depression and unfavorable outcomes associated with postnatal depression, researchers reported in” the findings of a “large prospective cohort study of 61,081 mother-child groups using longitudinal data from the Norwegian Mother, Father and Child Cohort Study” published online Aug. 29 in JAMA Network Open.
Related Links:
— “SSRIs may lower risk for postnatal depression-associated outcomes for mother and child,”Erin T. Welsh, Healio , September 6, 2023